GSK Bio
NEWS
The new factory will include cutting-edge technology, allowing production of three to four vaccines simultaneously, a massive improvement on the current limitation of one vaccine in an industrial site.
As biopharma companies focus on efficiencies and close sites, jobs are getting lost. Here’s a look.
In a stunning fall from grace playing out this week, former Operation Warp Speed vaccine czar, Dr. Moncef Slaoui, issued a statement Thursday morning, as news emerged that he has resigned from additional biotech posts.
Moncef Slaoui was fired as chairman of the board of directors of Galvani Bioelectronics following allegations of sexual harassment and inappropriate conduct.
It was a relatively quiet week in terms of clinical trial news, but there were some significant releases. Here’s a look.
Multiple pharmaceutical companies struck large licensing deals with one another this week. Here’s a look.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Topline data from Merck KGaA’s Phase II INTR@PID BTC 047 study show bintrafusp alfa has single-agent efficacy and safety in the second-line treatment of locally advanced or metastatic biliary tract cancer in patients who have either failed or are intolerant to first-line platinum-based chemotherapy.
The drug is a lipoglycopeptide antibiotic. It is given in a single, one-hour infusion.
JOBS
IN THE PRESS